Latest Parkinson's Stories
GRAND RAPIDS, Mich., Aug.
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
More Than 30 Scientific Projects Chosen for Potential to Improve the Lives and Futures of People Touched by Parkinson's NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- The Parkinson's
VIENNA, July 24, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
100% of donations raised will go to research KINGSTON, N.J., July 22, 2014 /PRNewswire-USNewswire/ -- Over 11,000 people from across the country came together on Saturday, April 26(th)
Initiative to optimize patient care spearheaded by AbbVie and The Michael J.
Volunteer Advisors Drive PDF Mission and Patient-Centric Approach NEW YORK, July 1, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased
- The act of sweetening by admixture of some saccharine substance.